Quest Diagnostics Incorporated (DGX) vs Incyte Corporation (INCY)
INCY leads on 13 of 16 compared metrics.
A side-by-side comparison of Quest Diagnostics Incorporated and Incyte Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 26, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
DGX
Quest Diagnostics Incorporated
$206.24Healthcare
INCY
Incyte Corporation
$107.53Healthcare
Total return — DGX vs INCY
growth of $100 · last 30yDGX +5792.6%INCY +845.3%DGX compounded faster
Log scale — wide-divergence pair
DGX INCY
DGX vs INCY: by the numbers
- •DGX is the larger company ($22.83B vs $21.48B market cap).
- •INCY trades at the lower earnings multiple (15.19 vs 22.79 P/E).
- •INCY converts more revenue to profit (26.71% vs 9.08% net margin).
- •INCY grew revenue faster over the past five years (14.68% vs 1.76% CAGR).
- •DGX pays a dividend (1.58% yield) while INCY does not currently pay one.
Which is better, DGX or INCY?
Metric tally: DGX 3 · INCY 13It depends on what you're optimizing for:
ValueINCY(lower P/E)
GrowthINCY(faster 5Y revenue CAGR)
QualityINCY(higher ROIC)
Metrics side by side
Valuation
| Metric | DGX | INCY |
|---|---|---|
| P/E ratio | 22.79 | 15.19● |
| Forward P/E | 17.67 | 12.08● |
| P/S ratio | 2.05● | 4.15 |
| P/B ratio | 3.14● | 4.01 |
| PEG ratio | 1.43 | 0.72● |
| EV / EBITDA | 13.98 | 10.06● |
| FCF yield | 5.74% | 6.52%● |
Profitability
| Metric | DGX | INCY |
|---|---|---|
| Gross margin | 33.23% | 92.48%● |
| Operating margin | 14.31% | 27.05%● |
| Net margin | 9.08% | 26.71%● |
| ROE | 13.90% | 25.79%● |
| ROIC | 8.43% | 20.58%● |
Dividends
| Metric | DGX | INCY |
|---|---|---|
| Dividend yield | 1.58% | — |
| Payout ratio | 36.75% | — |
Growth (annualized)
| Metric | DGX | INCY |
|---|---|---|
| Revenue CAGR (5Y) | 1.76% | 14.68%● |
| EPS CAGR (5Y) | -3.65% | 21.19%● |
| FCF CAGR (5Y) | -8.51% | 20.60%● |
| Total return CAGR (5Y) | 11.90%● | 4.37% |
Frequently asked
- Which is better, DGX or INCY?
- It depends on your goal. value: INCY (lower P/E); growth: INCY (faster 5Y revenue CAGR); quality: INCY (higher ROIC). Across all compared metrics, INCY leads 13 to 3.
- Is DGX or INCY cheaper?
- On trailing earnings, INCY is cheaper: DGX trades at a 22.79 P/E and INCY at 15.19.
- Which has grown faster, DGX or INCY?
- Over the past five years, INCY grew revenue faster — DGX at a 1.76% CAGR versus INCY at 14.68%.
- Does DGX or INCY pay a bigger dividend?
- DGX pays a dividend (1.58% yield) while INCY does not currently pay one.
- Is DGX or INCY more profitable?
- INCY runs the higher net margin — DGX at 9.08% versus INCY at 26.71%.
- Which has been the better investment, DGX or INCY?
- Over the past 10-year, DGX delivered the higher annualized total return — DGX at 12.28% versus INCY at 3.40%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Quest Diagnostics P/E ratioIncyte P/E ratioQuest Diagnostics dividend yieldIncyte dividend yieldQuest Diagnostics ROEIncyte ROEQuest Diagnostics operating marginIncyte operating marginQuest Diagnostics revenue growthIncyte revenue growthQuest Diagnostics free cash flowIncyte free cash flow
Quest Diagnostics & Incyte appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 26, 2026.